documents: FDA-2019-D-4751-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-D-4751-0001 | FDA | FDA-2019-D-4751 | Food and Drug Administration Reauthorization Act Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2019-12-13T05:00:00Z | 2019 | 12 | 2019-12-13T05:00:00Z | 2020-02-12T04:59:59Z | 2020-05-06T20:45:01Z | 2019-26877 | 0 | 0 | 090000648420c58d |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref